FGF21-based thearpeutics (New York University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFGF21-based thearpeutics (New York University)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York University
Active IndicationsN/A
Inactive IndicationsObesityMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A